1 / 5

Alzheimer's Drugs Market to Grow Rapidly by about 10% CAGR During 2024-2030

The Alzheimer's Drugs global market report analyzes market by Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Combination Drugs, Others), by Route of Administration (Oral, Injectable, Transdermal Patch), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and by geographic region (North America, Europe, Asia-Pacific, South America and Middle East & Africa for 2021-2030 period in terms of value in US$ million, projected from 2024 through 2030.

industryexperts
Download Presentation

Alzheimer's Drugs Market to Grow Rapidly by about 10% CAGR During 2024-2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ALZHEIMER'S DRUGS MARKET TO GROW RAPIDLY BY ABOUT 10% CAGR DURING 2024-2030 AND TOUCH $5 BILLION BY 2030

  2. A new report from Industry Experts, Inc. on "Alzheimer's Drugs Market", is introduced. According to this study, global market for Alzheimer's Drugs will likely maintain a robust CAGR of 9.9% during the 2024-2030 analysis period and reach a projected US$9.2 billion by 2030 from an estimated US$5.2 billion in 2024.

  3. Alzheimer's drugs market is analyzed in this report globally, covering the major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

  4. The global market for Alzheimer's drugs studied in this report with respect to Drug Class – Cholinesterase Inhibitors, NMDA Receptor Antagonists, Combination Drugs and Others (Including Monoclonal Antibodies, Anti-amyloid Beta, Nutritional supplements, and Pipeline Drugs); Route of Administration – Oral, Injectable and Transdermal Patch; and Distribution Channel – Hospital Pharmacy, Retail Pharmacy and Online Pharmacy.

  5. About Industry Experts, Inc. • Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. • For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

More Related